John Hamer Ab Cellera Biologics Inc. (ABCL) insider trading activity
John Hamer is Director of AbCellera Biologics Inc.. Currently has a direct ownership of 128,862 shares of ABCL, which is worth approximately $351,793. The most recent transaction as insider was on Sep 01, 2021, when has been sold 137,351 shares (Common Shares) at a price of $16.93 per share, resulting in proceeds of $2,325,352. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
129K
0%
3M change
0%
12M change
Total Value Held
$351,793
JOHN HAMER Transaction History
JH
John Hamer
Director
Vancouver, A1